COMT and MAO-A Polymorphisms and Obsessive-Compulsive Disorder: A Family-Based Association Study by Sampaio, Aline Santos et al.
RESEARCH ARTICLE
COMT andMAO-A Polymorphisms and
Obsessive-Compulsive Disorder: A Family-
Based Association Study
Aline Santos Sampaio1,2*, Ana Gabriela Hounie1, Kátia Petribú3, Carolina Cappi1,
Ivanil Morais1, Homero Vallada1, Maria Conceição do Rosário4, S. Evelyn Stewart5,6,
Jesen Fargeness7, Carol Mathews8, Paul Arnold9, Gregory L. Hanna10, Margaret Richter11,
James Kennedy12, Leonardo Fontenelle13, Carlos Alberto de Bragança Pereira14, David
L. Pauls6‡, Eurípedes Constantino Miguel1‡
1 Department and Institute of Psychiatry, Faculdade de Medicina da Universidade de São Paulo, São Paulo,
SP, Brazil, 2 Serviço Médico Universitário, Universidade Federal da Bahia (UFBA, Federal University of
Bahia), Salvador, BA, Brazil, 3 Universidade de Pernambuco (UPE, University of Pernambuco) Faculdade
de Ciências Médicas, Recife, PE, Brazil, 4 Universidade Federal de Sao Paulo (UNIFESP, Federal
University of São Paulo), São Paulo, SP, Brazil, 5 British Columbia Mental Health and Addictions Research
Institute, Vancouver, BC, Canada, 6 Psychiatric and Neurodevelopmental Genetics Unit (PNGU),
Massachusetts General Hospital, Boston, Massachusetts, United States of America, 7 Center for Human
Genetics Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America,
8 Department of Psychiatry, University of California, San Francisco, California, United States of America,
9 Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada,
10 Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, United States of America, 11 The
FrederickW. Thompson Anxiety Disorders Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario,
Canada, 12 Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada,
13 Programa de Ansiedade e Depressão, Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro
(IPUB/UFRJ), Rio de Janeiro, RJ, Brazil, 14 Department of Statistics, The Institute of Mathematics and
Statistics, University of São Paulo, SP, Brazil




Obsessive-compulsive disorder (OCD) is a common and debilitating psychiatric illness. Al-
though a genetic component contributes to its etiology, no single gene or mechanism has
been identified to the OCD susceptibility. The catechol-O-methyltransferase (COMT) and
monoamine oxidase A (MAO-A) genes have been investigated in previous OCD studies,
but the results are still unclear. More recently, Taylor (2013) in a comprehensive meta-anal-
ysis of genetic association studies has identified COMT andMAO-A polymorphisms in-
volved with OCD. In an effort to clarify the role of these two genes in OCD vulnerability, a
family-based association investigation was performed as an alternative strategy to the clas-
sical case-control design.
Methods
Transmission disequilibrium analyses were performed after genotyping 13 single-nucleo-
tide polymorphisms (eight in COMT and five inMAO-A) in 783 OCD trios (probands and
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their parents). Four different OCD phenotypes (from narrow to broad OCD definitions) and a
SNP x SNP epistasis were also analyzed.
Results
OCD, broad and narrow phenotypes,were not associated with any of the investigated
COMT andMAO-A polymorphisms. In addition, the analyses of gene-gene interaction did
not show significant epistatic influences on phenotype between COMT andMAO-A.
Conclusions
The findings do not support an association between DSM-IV OCD and the variants of
COMT orMAO-A. However, results from this study cannot exclude the contribution of these
genes in the manifestation of OCD. The evaluation of broader spectrum phenotypes could
help to understand the role of these and other genes in the pathophysiology of OCD and its
spectrum disorders.
Introduction
Obsessive-compulsive disorder (OCD) is characterized by repetitive thoughts (obsessions) and
repetitive behaviors (compulsions) that are unwanted, time consuming, egodystonic, and result
in significant functional impairment [1]. Various studies have demonstrated that the etiology
of OCD has a genetic component [2] with reported heritability rates ranging between 27% and
65% [3]. Although more than 140 candidate gene studies have been conducted, the findings
have been inconclusive due to small sample size and few study replications [4]. The etiology of
OCD seems to involve an interaction between environmental factors and several genes of small
effect [2]. Studies employing different methodological strategies (e.g., cerebral spinal fluid me-
tabolites measurements, pharmacological challenges, and drug treatment responses) all suggest
that abnormal serotonergic neurotransmission is one of the most consistent biological findings
in OCD [5]. Studies have also reported dopaminergic abnormalities in the basal ganglia and
nucleus accumbens, as well as altered glutamate transmission in other locations in OCD sam-
ples, thus suggesting that complex interactions between multiple neurotransmitter systems
may contribute to the phenotypic presentation of OCD [6]. This could be understood by a po-
tential dysfunction in enzymes that metabolize central nervous system neurotransmitters in
OCD. Two important enzymes of this type are catechol-O-methyltransferase (COMT) and
monoamine oxidase A (MAO-A).
COMT is an Mg2+-dependent enzyme involved in the inactivation of certain catechol-
amines (norepinephrine, epinephrine, and dopamine). The important role that COMT plays in
neuropsychiatric disorders has previously been described [7]. The most widely studied COMT
polymorphism is a single-nucleotide polymorphism (SNP) leading to a valine-to-methionine
substitution at codon 158 (val158met or rs4680), which results in a low-activity thermolabile
and a high-activity thermostable forms of the enzyme—the met(158) and val(158) alleles, respec-
tively [8].
A deletion within the 22q11 region, which includes the COMT region, causes velocardiofa-
cial syndrome, which increases the risk for many psychiatric disorders [9], including OCD
[10]. Although various studies have evaluated the association between COMT polymorphisms
and OCD, the findings have been inconclusive [4].
OCD Association Study of COMT andMAO-A
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The monoamine oxidases (MAO) are enzymes that catalyze the oxidation of monoamines,
which exist in two forms: MAO-A and MAO-B. Both forms are found bound to the outer
membrane of mitochondria in most cell types in the body but show different specificities.
MAO-A is present in catecholaminergic neurons in the brain and plays a preferencial role in
the metabolic degradation of several neurotransmitters, including serotonin, norepinephrine,
epinephrine, and dopamine. TheMAO-A gene maps to the p11.3 region on the X chromo-
some. The first evidence thatMAO-A could play an important role in human behavior was the
description of a large Dutch family that presented with a new form of mental retardation with
prominent behavioral abnormalities linked to the X chromosome. Several males in the family
were affected by this disturbance and exhibited aggressive behavior, with significant impulsivi-
ty, pyromania, suicide attempts, and sexually aberrant behavior [11,12].
Some studies that have investigated the association betweenMAO-A polymorphisms and
OCD, and they have produced controversial results [4]. The various methodologies, different
phenotype definitions, small sample sizes and diverse ethnic backgrounds of the populations
studied could be sources of bias contributing to the discrepant results obtained in previous
studies.
Recently, Taylor [13] performed a comprehensive meta-analysis of OCD genetic association
studies. A total of 230 polymorphisms from 113 genetic association studies were identified. In
the main meta-analysis, COMT andMAO-A polymorphisms were found to be associated with
OCD in males.
In this study, the transmission disequilibrium of COMT andMAO-A SNPs was analyzed in
OCD patients, using a family-based association approach. Given that family studies have
shown familial aggregation between OCD and different psychiatric disorders (e.g., tic disor-
ders, body dysmorphic disorder, skin picking, trichotillomania and anxiety disorders)
[14,15,16,17,18,19], these disorders were included as broader phenotypes in the analyses.
Methods
Participants
The sample consisted of 783 individuals meeting DSM-IV criteria for OCD, and their biologi-
cal parents. The OCD probands were recruited from specialized OCD clinics at Harvard Uni-
versity, the University of California- San Francisco, the University of Michigan, the University
of Toronto, as well as from two universities in Brazil—the University of São Paulo and the Uni-
versity of Pernambuco that participate from the Obsessive-Compulsive Foundation Genetics
Collaborative Subgroup. Most of the sample was studied in a genome-wide association study
[20]. The probands and their parents underwent structured clinical interviews. For subjects
who were 16 years of age, we employed the Structured Clinical Interview for DSM-IV Axis I
Disorders, Clinician Version [21]. For subjects who were< 16 years of age, we employed the
Schedule for Affective Disorders and Schizophrenia for School Aged Children—Present and
Lifetime Version (K-SADS-PL) [22]. In addition, all subjects were interviewed with the Yale-
Brown Obsessive Compulsive Scale [23] and the Yale Global Tic Severity Scale [24]. All of the
interviewers were trained mental health professionals (psychiatrists or psychologists). Reliabili-
ty evaluations were performed and best-estimate diagnoses were made. The assessment proce-
dures have previously been described in detail [25].
Ethics Statement
This work was performed in accordance with Declaration of Helsinki. The project was ap-
proved by the research ethics committees (IRB) at each of the participating institutions (In Per-
nambuco, Brazil: Complexo Hospitalar do Hospital Universitario Oswaldo Cruz e Pronto
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Socorro Cardiologico de Pernambuco, University of Pernambuco –HUOC/PROCAP #29/
2010; and In Sao Paulo, Brazil: Comissao de Etica para Analise de Projetos de Pesquisa do
Instituto de Psiquiatria da Faculdade de Medicina da Universidade de Sao Paulo—CAPPesq
IPqHCFMUSP #968/05; United States: University of California, San Francisco Committee on
Human Research—#10–00157; Institutional Review of the University of Michigan Medical
School (IRBMED) protocol #1992-0191; Canada: Toronto: Centre for Addiction and Mental
Health Research Ethics Board #368-2008). Written informed consent was obtained from all
adult participants and from the parents of those who were minors.
Narrow and Broad Phenotypes categories
In addition to the association analysis between COMT andMAO-A and DSM-IV OCD, addi-
tional analyses were performed in the Brazilian subsample (83 trios) using the broader pheno-
types described below.
Hypothesizing that OCD phenomenology (and not severity) could be influenced by
COMT and MAO-A genes, we examined the association of COMT and MAO-A polymor-
phisms and a broadly-defined OCD, which includes cases with OCD symptoms even when
they did not meet full DSM-IV criteria for OCD (subclinical OCD).Acknowledging that OCD
is part of a spectrum [26,27] that includes other anxiety disorders [19,28], body dysmorphic
disorder, and pathological grooming disorders (skin picking and trichotillomania) [17], these
conditions were collectively referred to as OCD spectrum disorders. The term ‘OCD spectrum
disorders’ includes DSM-IV OCD, subclinical OCD, together with the DSM-IV anxiety disor-
ders, body dysmorphic disorder, and pathological grooming disorders (skin picking and
trichotillomania).
In addition, since some studies have suggested that OCD could be grouped based on tic dis-
order comorbidity [29,30], analyses in the Brazilian subsample were also completed to examine
an association between COMT andMAO-A polymorphisms and OCD with tic disorder (Tour-
ette syndrome or chronic tic disorder) comorbidity.
Genotyping
DNA from peripheral blood samples were extracted using the “salting-out” protocol [31]. On
the basis of Tagger software [32], COMT andMAOA genomic regions were specified and tag
SNPs were picked (a local copy of HapMap data was used) within them. Tagger produced a list
of tag SNPs and corresponding statistical tests to capture all variants of interest, and a summary
coverage report of the selected tag SNPs. Eleven SNPs in the COMT gene region and six SNPs
in theMAO-A gene region were selected. These SNPs were genotyped at the Psychiatric and
Neurodevelopmental Genetics Unit of Massachusetts General Hospital, a teaching hospital as-
sociated with Harvard University. Genotyping was performed in 384-well plates with the
SequenomMassARRAY platform (Sequenom, San Diego, CA, USA). Primers for polymerase
chain reaction (PCR) amplification and single-base extension assays were designed using
Assay Design software, version 3.1 on the basis of FASTA sequences surrounding the SNPs, de-
rived from SNPper [33]. Multiplex PCR was performed, followed by a pooled single-base ex-
tension reaction (iPLEX Gold). Samples were analyzed with a MassARRAY RT mass
spectrometer, in automated mode. The resulting spectra were analyzed with SpectroTyper soft-
ware after baseline correction and peak identification (Sequenom). Information about the ten
COMT SNPs and the sixMAO-A SNPs was obtained from the dbSNP, Celera, and HapMap
databases. Three markers were excluded because of quality control issues: COMT rs2239393,
because the genotyping success rate was lower than 75%;MAO-A rs2179098, because the
minor allele frequency was 0.025; and COMT rs1544325, because the Hardy-Weinberg p
OCD Association Study of COMT andMAO-A
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value was< 0.05. The thirteen remaining SNPs collectively covered the COMT andMAO-A
gene regions: the eight selected COMT SNPs spanned 25.6 kb, with a density of 2.84 kb/SNP;
and the five selectedMAO-A SNPs spanned 63 kb, with a density of 12.6 kb/SNP. Single-mark-
er and haplotype analyses were performed in order to identify associations.
Statistical analysis
Statistical analyses were performed with the programs PLINK [34,35] and Haploview 3.32 [36].
Using the Haploview software, SNPs were selected on the basis of quality control criteria. 95% con-
fidence bounds on D prime are generated and each comparison is called "strong LD", "inconclusive"
or "strong recombination". A haplotype block is created if 95% of informative (i.e., non-inconclu-
sive) comparisons are "strong LD" [37]. Following this, the haplotype TDT analysis was performed.
For single markers association, the results of the standard transmission/disequilibrium test
(TDT) and the `parental discordance test` [34] were combined in order to calculate the p-
value using PLINK [34,35]. No covariate was added in the TDT analysis model. The `parental
discordance test`is based on a comparison between affected and unaffected parents in terms of
the number of alleles they carry, treating each parental pair as a matched case-control pair. The
`parental discordance test` assumes homogeneity, in terms of population stratification, within
rather than between nuclear families. This test can add power to family-based association anal-
yses, as well as provide considerable protection against population stratification [38].
In addition to the association analysis between COMT andMAO-A and DSM-IV OCD, a
secondary investigation of the COMT andMAO-A associations in our sample was completed.
First, probands were grouped into gender-matched trios in order to evaluate the influence of
gender on the results. This approach was based on the knowledge that COMT has influence on
estrogens [39] and thatMAO-A is located on the X chromosome.
Second, exploratory analyses were performed on the Brazilian subsample to consider as af-
fected status, some OCD-related phenotypes such as broadly-defined OCD (clinical plus sub-
clinical OCD), OCD spectrum disorders and OCD with comorbid tic disorders.
Third, since both COMT andMAOA are involved in dopamine catabolism, the gene- gene
interaction was evaluated in contributing to OCD etiology. It was used as the case-only epistat-
ic analysis under the SNP x SNP model, using PLINK software [34,35] in the whole sample
(783 trios). Only SNPs that are more than 1 Mb apart, or on different chromosomes, are in-
cluded in case-only analyses.
The statistical power of this study was calculated using Genetic Power Calculator [40].
The results were subject to permutation analysis (100,000 permutations) using Plink, in
order to control for false-positive association, and to Bonferroni`s correction for multiple anal-
ysis (corrected p-value threshold = 0.0004).
Results
Strictly-defined DSM-IV OCD phenotype
The results of the OCD association analysis of the eight COMT SNPs and fiveMAO-A SNPs
are described in Table 1. The TDT, the “parental discordance test”, and the combined test were
all not significant for the female (Table 2) and the male proband trios (Table 3).
Haplotypes
Two haplotype blocks were identified in each gene (Figs. 1 and 2). In the COMT gene (Fig. 1),
SNPs rs737866 and rs933271 compose block 1; and SNPs rs4646316 and rs165774 compose
block 2. In theMAO-A gene (Fig. 2), SNPs rs1465107 and rs1465108 compose block 1; and the
OCD Association Study of COMT andMAO-A
PLOSONE | DOI:10.1371/journal.pone.0119592 March 20, 2015 5 / 14
SNPs rs6323, rs979606, and rs979605 compose block 2. None of these haplotype blocks were
found to be associated with OCD (Figs. 1 and 2).
Epistasis analysis
None of the COMT orMAOA SNPs showed an epistatic interaction in association with OCD
(data not shown).
Table 1. Single-marker analysis of OCD association with catechol-O-methyltransferase andmonoamine oxidase A single-nucleotide
polymorphisms.
Gene SNP OR CHISQ P CHISQ_PAR P_PAR CHISQ_COM P_COM
COMT rs737866 0.756 6.127 0.013 2.286 0.131 7.86 0.005
rs933271 1.238 3.191 0.074 0.222 0.637 3.413 0.065
rs5993883 1.164 2.042 0.153 1.882 0.17 3.133 0.077
rs740603 0.97 0.091 0.762 2.574 0.109 0.057 0.812
rs4680 1.034 0.099 0.752 1 0.317 0.002 0.96
rs4646316 0.851 1.766 0.184 0.143 0.706 1.325 0.25
rs165774 0.988 0.012 0.911 0.037 0.847 0.026 0.872
rs9332377 0.88 0.832 0.362 0.6 0.439 1.174 0.278
MAO-A rs1465107 0.957 0.066 0.798 0.4 0.527 0.277 0.599
rs1465108 1.016 0.008 0.929 0.026 0.873 0 1
rs6323 1.014 0.007 0.934 1.4 0.237 0.2 0.655
rs979606 1.094 0.269 0.604 0.471 0.493 0.024 0.877
rs979605 1.103 0.343 0.558 0.641 0.423 0.022 0.882
SNP: single-nucleotide polymorphism; TDT: transmission/disequilibrium test; OR: TDT odds ratio; CHISQ: TDT chi-square value; P: TDT p value;
CHISQ_PAR: parental discordance test chi-square value; P_PAR: parental discordance test p value; CHISQ_COM: combined test chi-square value;
P_COM: combined test p value; COMT: catechol-O-methyltransferase; MAO-A: monoamine oxidase-A
doi:10.1371/journal.pone.0119592.t001
Table 2. Analysis of OCD association with catechol-O-methyltransferase andmonoamine oxidase A single-nucleotide polymorphisms in female
proband trios.
Gene SNP OR CHISQ P CHISQ_PAR P_PAR CHISQ_COM P_COM
COMT rs737866 0.649 5.541 0.019 0.4 0.527 5.939 0.015
rs933271 1.137 0.449 0.503 0.667 0.414 0.217 0.641
rs5993883 1.463 4.699 0.03 2.579 0.108 6.737 0.009
rs740603 1.295 2.314 0.128 4.167 0.041 4.78 0.029
rs4680 1.293 2.173 0.14 0.4 0.527 1.573 0.21
rs4646316 0.893 0.34 0.56 0 1 0.3 0.585
rs165774 0.875 0.533 0.465 1 0.317 0.194 0.66
rs9332377 0.783 1.22 0.269 0.111 0.739 0.89 0.345
MAO-A rs1465107 1.083 0.08 0.777 0.067 0.796 0.015 0.901
rs1465108 1.087 0.083 0.773 0.067 0.796 0.016 0.9
rs6323 1.24 0.643 0.423 0.692 0.405 0.13 0.718
rs979606 1.2 0.455 0.5 0.692 0.405 0.059 0.808
rs979605 1.269 0.83 0.362 0.692 0.405 0.222 0.637
SNP: single-nucleotide polymorphism; TDT: transmission/disequilibrium test; OR: TDT odds ratio; CHISQ: TDT chi-square value; P: TDT p value;
CHISQ_PAR: parental discordance test chi-square value; P_PAR: parental discordance test p value; CHISQ_COM: combined test chi-square value;
P_COM: combined test p value; COMT: catechol-O-methyltransferase; MAO-A: monoamine oxidase-A
doi:10.1371/journal.pone.0119592.t002
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Power calculation for whole sample
The statistical power for this association analysis (783 trios, high risk allele frequency = 0.478;
OCD prevalence = 0.025; alpha = 0.05) was 65% in average for COMT gene (1120 trios were
needed to achieve 80% power) and 58% in average forMAOA (783 trios, high risk allele fre-
quency = 0.257; OCD prevalence = 0.025; alpha = 0.05; and 1305 trios needed to achieve 80%
power).
A secondary analysis was performed, with the Brazilian subsample, as described below:
Table 3. Analysis of OCD association with catechol-O-methyltransferase andmonoamine oxidase A single-nucleotide polymorphisms in male
proband trios.
Gene SNP OR CHISQ P CHISQ_PAR P_PAR CHISQ_COM P_COM
COMT rs737866 0.827 1.705 0.192 0.889 0.346 2.327 0.127
rs933271 1.28 2.579 0.108 0.111 0.739 2.689 0.101
rs5993883 1.037 0.073 0.786 0.067 0.796 0.107 0.743
rs740603 0.851 1.613 0.204 0.043 0.835 1.332 0.248
rs4680 0.955 0.114 0.736 1 0.317 0.345 0.557
rs4646316 1.099 0.424 0.515 0.889 0.346 0.12 0.73
rs165774 0.918 0.214 0.644 2.667 0.102 0.658 0.417
rs9332377 0.954 0.048 0.827 0 1 0.037 0.847
MAO-A rs1465107 1.054 0.053 0.818 0.037 0.847 0.087 0.768
rs1465108 0.954 0.046 0.829 0.222 0.637 0.154 0.695
rs6323 1.111 0.21 0.646 0.048 0.827 0.094 0.761
rs979606 1.077 0.111 0.739 0 1 0.087 0.768
rs979605 0.827 1.705 0.192 0.889 0.346 2.33 0.127
SNP: single-nucleotide polymorphism; TDT: transmission/disequilibrium test; OR: TDT odds ratio; CHISQ: TDT chi-square value; P: TDT p value;
CHISQ_PAR: parental discordance test chi-square value; P_PAR: parental discordance test p value; CHISQ_COM: combined test chi-square value;
P_COM: combined test p value; COMT: catechol-O-methyltransferase; MAO-A: monoamine oxidase-A
doi:10.1371/journal.pone.0119592.t003
Fig 1. Catechol-O-methyltransferase haplotype blocks composed by single nucleotide polymorphisms evaluated. Two haplotype blocks, with two
SNPs each, were defined in Cathecol-O-methyltransferase. Block 1 comprises SNP rs737866 and rs933271 and Block 2 comprises SNPs rs4646316 and
rs165774. Darker squares mean the high D prime and high LOD scores. Haplotype blocks were defined with D prime scores higher than 95. When D prime is
100, the number is not shown inside the square. Two haplotype blocks, with two SNPs each, were defined in Cathecol-O-methyltransferase. Data shown in
the table refers to each haplotypes allele combination association results.
doi:10.1371/journal.pone.0119592.g001
OCD Association Study of COMT andMAO-A
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Strictly-defined OCD with comorbid tic disorders
When the Brazilian patients with OCD and comorbid tic disorders (Tourette syndrome or
chronic tic disorders; N = 19 trios) were analyzed separately, OCD with comorbid tic disorder
was not found to be significantly associated with any COMT orMAO-A SNP (S1 Table).
Broadly-defined OCD phenotype
When the Brazilian subjects meeting criteria for subclinical and clinical OCD are included to-
gether, there was preferential transmission of the A allele of theMAO-A SNP rs1465108
(p = 0.0469) (S2 Table). This finding did not remain significant after 100,000 permutations nor
after Bonferroni`s correction.
Broadly-defined OCD spectrum disorders
Subsequent analyses revealed that the A allele of theMAO-A SNP rs979605 was associated
with OCD spectrum disorders (as defined above: including patients with OCD, subclinical
OCD, skin picking, trichotillomania, body dysmorphic disorder, or DSM-IV-defined anxiety
disorders) (p = 0.027) (S3 Table). This finding also did not remain significant after 100,000 per-
mutations nor after Bonferroni`s correction.
Power calculation for Brazilian subsample
The statistical power for the analyses performed with the Brazilian subsample (83 trios; high
risk allele frequency = 0.39; OCD prevalence = 0.025; alpha = 0.05) was 11% (1282 trios needed
for 80% power) for COMT; and forMAOA would be 10.5% power (83 trios; high risk allele fre-
quency = 0.32; OCD prevalence = 0.025; alpha = 0.05; and 1402 trios needed for 80% power)
Discussion
The results presented here do not support the hypothesis that DSM-IV OCD diagnosis is asso-
ciated withMAO-A or COMT. Results were also negative in the additional analyses performed:
1) one that examined a strictly defined phenotype that consisted of individuals with OCD and
tic disorders; 2) one that examined a broadly defined phenotype that included OCD, subclinical
OCD; 3) one that included other OCD spectrum disorders; and 4) one COMT-MAOA
epistasis analysis.
Fig 2. Monoamine oxidase A haplotype Block comprises SNPs rs1465107 and rs1465108 and Block 2 comprises the SNPs rs6323, rs979606, and
rs979605. 1 composed by single nucleotide polymorphisms evaluated. Darker squares mean the high D prime and high LOD scores. Haplotype blocks were
defined with D prime scores higher than 95. When D prime is 100, the number is not shown inside the square. Data shown in the table refers to each
haplotypes allele combination association results.
doi:10.1371/journal.pone.0119592.g002
OCD Association Study of COMT andMAO-A
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This result is consistent with the findings of a previous Brazilian study where no association
between DSM-IV OCD and the COMT val-158-met (rs4680) variant in a case-control OCD
study was observed (Meira-Lima et al. 2004).
As with any genetic association study, the present work is not without its limitations. The
main limitation is the small sample size. The statistical power to refute the null hypothesis in
this study was 23% (COMT) and 21% (MAOA) for the whole sample and 11% (COMT) and
10.5% (MAOA) for the analyses performed solely on the Brazilian subsample.
The most recent meta-analysis evaluated about 810 OCD cases and found a positive associa-
tion between COMT rs4680 and OCD in males [41]. These analyses had a power of 49.9% for
the total sample and 30.75% for the male sample. As mentioned previously, about 1800 OCD
trios were needed to achieve 80% statistical power in a COMT rs4680 and OCD association
study [40].
The same meta-analysis evaluated about 452 OCD probands regarding theMAOA EcoRV
polymorphism and found a significant association between T allele and OCD in males [41].
This meta-analysis reached 17.2% statistical power for theMAOA polymorphism. The sample
number needed to reach 80% power would be more than 2,000 trios [40].
Therefore, the accumulated empirical data to date on the association of COMT andMAOA
polymorphisms and OCD are not enough to refute the null hypothesis and thus, additional as-
sociation studies are needed to add power in future meta-analyses.
Another limitation was the number of tests performed in this study (more than 120 tests).
The multitesting could increase the odds of false positive results. None of the results remained
significant after Bonferroni`s correction or permutation analysis. Other investigators, who also
had small sample studies, have reported associations between COMT and other psychiatric
conditions, such as schizophrenia [42,43,44,45,46,47,48,49,50], bipolar disorder [47,50,51]; al-
coholism [52,53], substance use disorders [54,55], depression [56,57], and anorexia nervosa
[58]. Likewise,MAO-A has been associated with attention deficit hyperactivity disorder [59],
anxiety disorders [60], major depressive disorder [61], and other psychiatric conditions
[9,62,63]. Besides the odds of some false-positive associations, the non-specificity of the pheno-
types associated with the COMT andMAO-A genes might be related to their metabolic func-
tions. Because the COMT andMAO-A enzymes metabolize a number of important
neurotransmitters in the limbic pathways, it is possible that, from a phenomenological perspec-
tive, impairment of their function could lead to various psychological presentations. Besides,
underlying psychopathology of correlated mental disorders are hypothesized to be dimensional
and continuous and to share genetic etiologic factors [64].
Additionally, the genetic heterogeneity of the sample could be another limitation, since the
Brazilian population is an admixture of individuals of European, African and indigenous de-
scent. However, the use of a family-based approach in conjunction with the `parental discor-
dance test` minimized the odds of population stratification bias.
In conclusion, the present work investigated eight SNPs from COMT gene, five from
MAO-A gene and the interaction between these two genes in 783 OCD trios using transmission
disequilibrium linkage analyses. Analyses using three phenotype variations (from narrow to
broad definitions of OCD phenotypes), showed only no significant association. Despite the
lack of association, it appears that the broadly-defined OCD, as well as the OCD spectrum dis-
orders, may be interesting phenotypes to be studied in future association analysis. Further ge-
netic association studies with larger samples involving a more comprehensive coverage of
polymorphisms in the COMT andMAO-A genes, as well as other meta-analyses, are needed in
order to clarify the biological effect of those genes over the OCD susceptibility phenotypes.
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